However, some research suggests that tirzepatide may lead to more weight loss than semaglutide
Based on Phase 2 trial data (Jastreboff et al., NEJM 2023), retatrutide's side effect profile appears broadly consistent with other GLP-1-based therapies, though the addition of glucagon receptor agonism introduces some distinct considerations
Oxidative stress is associated with the pathology of various viral infections, including SARS-CoV-2, IAV, HCV, ZIKV, and HIV infections
With these results, Hims signals a clear strategic focus on longevity and preventive medicine
Ongoing research involving the retatrutide peptide is examining how multi-pathway hormonal activity may influence metabolism and fat storage